Development of a mouse model system, coding assignments and identification of the genome segments controlling virulence of African horse sickness virus serotypes 3 and 8

  • R. S. O’Hara
  • A. J. Meyer
  • J. N. Burroughs
  • L. Pullen
  • L.-A. Martin
  • P. P. C. Mertens
Conference paper


Attenuated (att) and wild type (wt) strains of the nine AHSV serotypes were evaluated for virulence in adult Balb C mice. Although most were avirulent in this system, isolates of AHSV latt, 3wt, 3att, 4wt, 4att, 5att, 7att and 8att caused some mortality when administered via an intranasal route. After plaque cloning, only the attenuated vaccine strain of AHSV 7att caused any mortality via an intravenous route. AHSV 3att and AHSV 8wt were virulent (V) and avirulent (AV) (respectively) in the mouse model and were selected as parental strains for production of genome segment reassortants. These progeny virus strains were plaque cloned, then characterised to identify the genome segments that influence virulence of AHSV in the mouse model.

Three virulence phenotypes were observed: fully virulent (V); fully avirulent (A); and a novel intermediate virulence (N) not expressed by either parental strain. Genome segment 2 (encoding outer capsid protein VP2) from the avirulent parent appeared to have a controlling influence in production of the A phenotype. Reassortants with the V phenotype all contained segment 2 from the virulent parent, however in each case they also contained genome segments 5 and 10, also from AHSV 3 (V). Genome segments 5 and 10 encode the smaller outer capsid protein VP5 and the non structural proteins NS3/NS3a, respectively. A combination of genome segments 2, 5 and 6 from the avirulent parent and segment 10 from the virulent parent were found in each of the virus strains with the N phenotype. However, comparison of two reassortants (A79 and A790), which differ only in a single segment, showed that replacement of genome segment 10 from the avirulent parent with that from the virulent parent, conferred the N phenotype on A790.


Vaccine Strain Genome Segment Virulent Parent Virulence Phenotype Bluetongue Virus 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Brookes SM, Hyatt AD, Eaton BT (1993) Characterization of virus inclusion bodies in bluetongue virus-infected cells. J Gen Virol 74: 525–530PubMedCrossRefGoogle Scholar
  2. 2.
    Burrage TG, Trevejo R, Stonemarschat M, Laegreid WW (1993) Neutralizing epitopes of African horse sickness virus serotype-4 are located on VP2. Virology 196: 799–803PubMedCrossRefGoogle Scholar
  3. 3.
    Burroughs JN, O’Hara RS, Smale CJ, Hamblin C, Walton A, Armstrong R, Mertens PPC (1994) Purification and properties of virus particles, infectious sub viral particles, cores and VP7 crystals of African horse sickness virus serotype 9. J Gen Virol 75: 1849–1857PubMedCrossRefGoogle Scholar
  4. 4.
    Calisher CH, Mertens PPC (1998) Taxonomy of African horse sickness viruses. In: Mellor PS, Baylis M, Hamblin C, Calisher CH, Mertens PPC (eds) African horse sickness. Springer, Wien New York, pp 3–11 (Arch Virol [Suppl] 14 )Google Scholar
  5. 5.
    Cowley JA, Gorman BM (1989) Cross-neutralization of genetic reassortants of blue-tongue virus serotypes 20 and 21. Vet Microbiol 19: 37–51PubMedCrossRefGoogle Scholar
  6. 6.
    de Sa RO, Zenner M, Grubman MJ (1994) Phylogenetic analysis of segment 10 from African horse sickness virus and cognate genes from other orbiviruses. Virus Res 33: 157–165PubMedCrossRefGoogle Scholar
  7. 7.
    Devi R, Burroughs JN, Mertens PPC, Roy P (1998) Transmethylase 1 and Transmethylase 2 activities associated with the Cap protein (VP4) of BTV, in native cores, core like particles and as a purified, baculovirus expressed protein. (submitted)Google Scholar
  8. 8.
    Eaton BT, Hyatt AD, Brookes SM (1990)The replication of bluetongue virus. Curr Top Microbiol Immunol 162: 89–118PubMedGoogle Scholar
  9. 9.
    Finney DJ (1964) Statistical method in biological assay, 2nd ed. Griffin, LondonGoogle Scholar
  10. 10.
    Fu H (1996) Mechanisms controlling the infection of Culicoides biting midges with bluetongue virus. Ph.D. Thesis, University of HertfordshireGoogle Scholar
  11. 11.
    Fu H, Leake CJ, Mertens PPC, Mellor PS, The barriers to bluetongue virus infection dissemination and transmission in the vector Culicoides variipennis (Diptera: Ceratopogonidae) (submitted)Google Scholar
  12. 12.
    Gouet P, Grimes JM, Diprose JM, Malby R, Burroughs JN, Zeintara S, Stuart, DI, Mertens PPC (1998) Crystallographic studies show ordered double-stranded RNA in bluetongue virus (submitted)Google Scholar
  13. 13.
    Grimes JM, Burroughs JN, Gouet P, Diprose JM, Malby R, Zeintara S, Mertens PPC, Stuart DI (1998) The atomic structure of the bluetongue virus core. Nature (in press)Google Scholar
  14. 14.
    Grubman MJ, Lewis SA (1992) Identification and characterization of the structural and non structural proteins of AHSV and determination of the genome coding assignments. Virology 186: 444–451PubMedCrossRefGoogle Scholar
  15. 15.
    Hewat EA, Booth TF, Roy P (1992) Structure of bluetongue virus particles by cryoelectron microscopy. J Struct Biol 109: 61–69PubMedCrossRefGoogle Scholar
  16. 16.
    Hewat EA, Booth TF, Wade RH, Roy P (1992) 3-D reconstruction of bluetongue virus tubules using cryo-electron microscopy. J Struct Biol 108: 35–38PubMedCrossRefGoogle Scholar
  17. 17.
    Huismans H, Els HJ (1979) Characterization of tubules associated with the replication of the different orbiviruses. Virology 92: 397–406PubMedCrossRefGoogle Scholar
  18. 18.
    Huismans H, Van Der Walt NT, Cloete M, Erasmus BJ (1987) Isolation of a capsid protein of bluetongue virus that induces a protective immune response in sheep. Virology 61: 3589–3595Google Scholar
  19. 19.
    Huismans H, Van Dijk AA (1990) Bluetongue virus structural components. Curr Top Microbiol Immunol 162: 21–42PubMedGoogle Scholar
  20. 20.
    Huismans H, Van Dijk AA, Bauskin AR (1987) In vitro phosphorylation and purification of nonstructural protein of bluetongue virus with affinity for single stranded RNA. J Virol 61: 3589–3595PubMedGoogle Scholar
  21. 21.
    Huismans H, Van Dijk AA, Els HJ (1987) Uncoating of parental bluetongue virus to cores and subcore particles in infected L cells. Virology 157: 180–188PubMedCrossRefGoogle Scholar
  22. 22.
    Hwang G, Yang Y, Chiou J, Li JK (1992) Sequence conservation among the cognate nonstructural NS3/3A protein genes of six bluetongue viruses. Virus Res 23: 151–161PubMedCrossRefGoogle Scholar
  23. 23.
    Hyatt AD, Gould AR, Coupar B, Eaton BT (1991) Localization of the non-structural protein NS3 in bluetongue virus-infected cells. J Virol 72: 2263–2267CrossRefGoogle Scholar
  24. 24.
    Hyatt AD, Zhao Y, Roy P (1993) release of bluetongue virus-like particles from insect cells is mediated by BTV non-structural protein NS3/3a. Virology 193: 592–603Google Scholar
  25. 25.
    Laegried WW, Burrage TG, Stone-Marschat MA, Skrowronek AJ, Hussein A (1995) The S10 gene of African horse sickness virus is a major virulence determinant. Abstracts, Fifth International Symposium on double-stranded RNA viruses (P46)Google Scholar
  26. 26.
    Laemmli UK (1970) Cleavage of structural proteins during assembly of the head of bacteriophage T4. Nature 227: 680–685PubMedCrossRefGoogle Scholar
  27. 27.
    Lee JW, Roy P (1986) Nucleotide sequence of a cDNA clone of RNA segment 10 of bluetongue virus (serotype 10). J Gen Virol 67: 2833–2837PubMedCrossRefGoogle Scholar
  28. 28.
    Loudon PT, Roy P (1991) Assembly of five bluetongue virus proteins expressed by recombinant baculoviruses: inclusion of the largest protein VP1 in the core and virus like particles. Virology 180: 798–802PubMedCrossRefGoogle Scholar
  29. 29.
    Martin L-A, Mertens PPC (1998) Purification and characterisation of viral ds RNA genome profiles by cross hybridisation. Methods Mol Biol (in press)Google Scholar
  30. 30.
    Martin L-A, Meyer AJ, O’Hara RS, Fu H, Mellor PS, Knowles NJ, Mertens PPC (1988) Phylogenetic analysis of African horse sickness virus segment 10: sequence variation, virulence characteristics and cell exit. In: Mellor PS, Baylis M, Hamblin C, Calisher CH, Mertens PPC (eds) African horse sickness. Springer, Wien New York, pp 281–293 (Arch Virol [Suppl] 14 )Google Scholar
  31. 31.
    McCrae MA, Joklik WK (1978) The nature of the polypeptides encoded by each of thee 10 double stranded RNA segments of reovirus type 3. Virology 89: 578–593PubMedCrossRefGoogle Scholar
  32. 32.
    Meiswinkel R (1998) The imicola group (subgenus Avaritia): Short notes on the taxonomy, biology and geographic distribution of 10 species. In: Mellor PS, Baylis M, Hamblin C, Calisher CH, Mertens PPC (eds) African horse sickness. Springer, Wien New York, pp 69–83 (Arch Virol [Suppl] 14 ).Google Scholar
  33. 33.
    Mellor PS, Rawlings P, Baylis M, Welby MP (1998) Effect of temperature on African horse sickness virus infection in Culicoides. In: Mellor PS, Baylis M, Hamblin C, Calisher CH, Mertens PPC (eds) African horse sickness. Springer, Wien New York, pp 155–163 (Arch Virol [Suppl] 14 )Google Scholar
  34. 34.
    Mertens PPC (1994) Orbiviruses and coltiviruses — general features. In: Webster RG, Granoff A (eds) Encyclopedia of virology, vol 2. Academic Press, London, pp 941–956Google Scholar
  35. 35.
    Mertens PPC, Burroughs JN, Anderson J (1987) Purification and properties of virus particles, infectious subviral particles, and cores of bluetongue virus serotype 1 and 4. Virology 157: 375–386PubMedCrossRefGoogle Scholar
  36. 36.
    Mertens PPC, Burroughs JN, Walton A, Wellby MP, Fu H, O’Hara RS, Brookes SM, Mellor PS (1996) Enhanced infectivity of modified bluetongue virus particles for two insect cell lines and for two Culicoides vector species. Virology 217: 582–593PubMedCrossRefGoogle Scholar
  37. 37.
    Mertens PPC, Burroughs JN, Wade-Evans AM, Le Blois H, Oldfield S, Basak A, Loudon P, Roy P (1992) Analysis of guanylyltransferase and transmethylase activities associated with bluetongue virus cores and recombinant baculovirus-expressed core-like particles. In: Walton TE, Osburn BI (eds) Bluetongue, African horse sickness and related orbiviruses Second International Symposium on bluetongue, African horse sickness and related orbiviruses. CRC Press, Boca Raton, pp 404–415Google Scholar
  38. 38.
    Mertens PPC, Brown F, Sangar DV (1984) Assignment of the genome segments of bluetongue virus type 1 to the proteins which they encode. Virology 135: 207–217PubMedCrossRefGoogle Scholar
  39. 39.
    Mertens PPC, Pedley S, Cowley JA, Corteyn AH, Jeggo MH, Jennings DM, Gorman BM (1989) Analysis of the roles of bluetongue virus outer capsid proteins VP2 and VP5 in determination of virus serotype. Virology 170: 561–565PubMedCrossRefGoogle Scholar
  40. 40.
    Mertens PPC Sangar DV (1985) Analysis of the terminal sequences of the genome segments of four orbiviruses. Virology 140: 55–67PubMedCrossRefGoogle Scholar
  41. 41.
    Mertens PPC, et al (in preparation) Family Reoviridae. In: Seventh Report of the International Committee on Taxonomy of VirusesGoogle Scholar
  42. 42.
    Moss SR, Jones LD, Nuttall PA (1992) Comparison of the nonstructural protein, NS3, of tick-borne and insect-borne orbiviruses. Virology 187: 841–844PubMedCrossRefGoogle Scholar
  43. 43.
    Moss SR, Nuttall PA (1994) Subcore and core-like particles of Broadhaven virus (BRDV), a tick boume orbivirus, synthesised from baculovirus expressed VP2 and VP7, the major core proteins of BRDV. Virus Res 32: 401–407PubMedCrossRefGoogle Scholar
  44. 44.
    O’Hara RS (1994) Identification of the genome segments and proteins controlling the virulence of African horse sickness virus. Ph.D. Thesis, University of ReadingGoogle Scholar
  45. 45.
    Pedley S, Mohamed MEH, Mertens PPC (1988) Analysis of the genome segments of six different bluetongue virus isolates using RNA-RNA hybridisation: a generalised coding assignment for bluetongue viruses. Virus Res 10: 381–390PubMedCrossRefGoogle Scholar
  46. 46.
    Sailleau C, Moulay S, Zientara S (1997) Nucleotide sequence comparison of the segments S10 of the nine African horse sickness virus serotypes. Arch Virol 142: 965–978PubMedCrossRefGoogle Scholar
  47. 47.
    Stonemarschat MA, Moss SR, Burrage TG, Barber ML, Roy P, Laegreid WW (1996) Immunization with VP2 is sufficient for protection against lethal challenge with African horse sickness virus type-4. Virology 220: 219–222CrossRefGoogle Scholar
  48. 48.
    Stuart DI, Gouet P, Grimes J, Malby R, Diprose J, Zientara S, Burroughs JN, Mertens PPC (1998) Orbivirus particle structure. In: Mellor PS, Baylis M, Hamblin C, Calisher CH, Mertens PPC (eds) African horse sickness. Springer, Wien New York, pp 235–250 (Arch Virol [Suppl] 14 )Google Scholar
  49. 49.
    Swanepoel R, Erasmus BJ, Williams R, Taylor MB (1992) Encephalitis and chorioretinitis associated with neurotropic African horse sickness virus infection in laboratory workers. Part III. Virological and serological investigations. S Afr Med J 81: 458–461PubMedGoogle Scholar
  50. 50.
    Thomas CP, Booth TF, Roy P (1990) Synthesis of bluetongue virus encoded phosphoprotein and formation of inclusion bodies by recombinant baculovirus in insect cells: it binds the single stranded RNA species. J Gen Virol 71: 2073–2083PubMedCrossRefGoogle Scholar
  51. 51.
    Van Dijk AA, Huismans H (1988) The in vitro activation and further characterisation of the bluetongue virus associated transcriptase. Virology 104: 347–356CrossRefGoogle Scholar
  52. 52.
    van Staden V, Huismans H (1991) A comparison of the genes which encode nonstructural protein NS3 of different orbiviruses. J Gen Virol 72: 1073–1079PubMedCrossRefGoogle Scholar
  53. 53.
    van Staden V, Stoltz MA, Huismans H (1995) Expression of nonstructural protein NS3 of African horse sickness virus (AHSV): evidence for a cytotoxic effect of NS3 in insect cells, and characterization of the gene products in AHSV infected Vero cells. Arch Virol 140: 289–306PubMedCrossRefGoogle Scholar
  54. 54.
    Wade-Evans AM, Pullen L, Hamblin C, O’Hara RS, Burroughs JN, Mertens PPC (1997) African horse sickness virus, VP7, subunit vaccine protects mice against a lethal heterologous serotype challenge. J Gen Virol 78: 1611–1616PubMedGoogle Scholar
  55. 55.
    Wade-Evans AM, Pullen L, Hamblin C, O’Hara RS, Burroughs JN, Mertens PPC (1998) VP7 from African horse sickness virus serotype 9 protects mice against a lethal, heterologous serotype challenge. In: Mellor PS, Baylis M, Hamblin C, Calisher CH, Mertens PPC (eds) African horse sickness. Springer, Wien New York, pp 211–219 (Arch Virol [Suppl] 14 )Google Scholar
  56. 56.
    Wu X, Chen S-Y, Iwata H, Compans RW, Roy P (1992) Multiple glycoproteins synthesized by the smallest RNA segment (S10) of bluetongue virus. J Virol 66: 7104–7112PubMedGoogle Scholar
  57. 57.
    Zientara S, Sailleau C, Moulay S, Crucière C (1995) Differentiation of African horse sickness viruses by polymerase reaction and segment 10 restriction patterns. Vet Microbiol 47: 365–375PubMedCrossRefGoogle Scholar
  58. 58.
    Zientara S, Sailleau C, Plateau E, Moulay S, Mertens PPC, Crucière C (1998) Molecular epidemiology of African horse sickness virus based on analyses and comparisons of genome segments 7 and 10. In: Mellor PS, Baylis M, Hamblin C, Calisher CH, Mertens PPC (eds) African horse sickness. Springer, Wien New York, pp 221–234 (Arch Virol [Suppl] 14 )Google Scholar

Copyright information

© Springer-Verlag/Wien 1998

Authors and Affiliations

  • R. S. O’Hara
    • 1
  • A. J. Meyer
    • 1
  • J. N. Burroughs
    • 1
  • L. Pullen
    • 1
  • L.-A. Martin
    • 1
  • P. P. C. Mertens
    • 2
  1. 1.Pirbright LaboratoryInstitute for Animal HealthWokingUK
  2. 2.Pirbright LaboratoryInstitute for Animal HealthPirbright, Woking, SurreyUK

Personalised recommendations